Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Erlichman

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Journal of Neurosurgery|August 1, 1994
Necrosis in a meningioma following systemic chemotherapy. Case reportM Bernstein, A Villamil, G Davidson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Biochemical effects of folate-based inhibitors of thymidylate synthase in MGH-U1 cellsB Mitrovski, J Pressacco, S Mandelbaum, et al.
Anti-Cancer Drugs|October 1, 1993
A phase II study of 5-fluorouracil, leucovorin and interferon-alpha in advanced pancreatic cancerM J Moore, C Erlichman, L Kaizer, et al.
Cancer Research|April 1, 1995
Effects of thymidylate synthase inhibition on thymidine kinase activity and nucleoside transporter expressionJ Pressacco, B Mitrovski, C Erlichman, et al.
Canadian Journal of Physiology and Pharmacology|March 1, 1987
Mitomycin C pharmacokinetics in patients with recurrent or metastatic colorectal carcinomaC Erlichman, A M Rauth, R Battistella, et al.
Cancer Chemotherapy and Pharmacology|October 15, 1998
Effect of adding the topoisomerase I poison 7-ethyl-10-hydroxycamptothecin (SN-38) to 5-fluorouracil and folinic acid in HCT-8 cells: elevated dTTP pools and enhanced cytotoxicityS Mullany, P A Svingen, S H Kaufmann, et al.
Breast Cancer Research and Treatment|January 1, 1994
Phase II trial of 5-fluorouracil and folinic acid in the treatment of advanced breast cancerS Fine, C Erlichman, L Kaizer, et al.
Breast Cancer Research and Treatment|October 1, 1990
RECPAM analysis of prognostic factors in patients with stage III breast cancerC Erlichman, P Warde, T Gadalla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1990
Phase I/II trial of granisetron: a novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomitingM Addelman, C Erlichman, S Fine, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acidJ Steinberg, C Erlichman, T Gadalla, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Journal of Neurosurgery|August 1, 1994
Necrosis in a meningioma following systemic chemotherapy. Case reportM Bernstein, A Villamil, G Davidson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Biochemical effects of folate-based inhibitors of thymidylate synthase in MGH-U1 cellsB Mitrovski, J Pressacco, S Mandelbaum, et al.
Anti-Cancer Drugs|October 1, 1993
A phase II study of 5-fluorouracil, leucovorin and interferon-alpha in advanced pancreatic cancerM J Moore, C Erlichman, L Kaizer, et al.
Cancer Research|April 1, 1995
Effects of thymidylate synthase inhibition on thymidine kinase activity and nucleoside transporter expressionJ Pressacco, B Mitrovski, C Erlichman, et al.
Canadian Journal of Physiology and Pharmacology|March 1, 1987
Mitomycin C pharmacokinetics in patients with recurrent or metastatic colorectal carcinomaC Erlichman, A M Rauth, R Battistella, et al.
Cancer Chemotherapy and Pharmacology|October 15, 1998
Effect of adding the topoisomerase I poison 7-ethyl-10-hydroxycamptothecin (SN-38) to 5-fluorouracil and folinic acid in HCT-8 cells: elevated dTTP pools and enhanced cytotoxicityS Mullany, P A Svingen, S H Kaufmann, et al.
Breast Cancer Research and Treatment|January 1, 1994
Phase II trial of 5-fluorouracil and folinic acid in the treatment of advanced breast cancerS Fine, C Erlichman, L Kaizer, et al.
Breast Cancer Research and Treatment|October 1, 1990
RECPAM analysis of prognostic factors in patients with stage III breast cancerC Erlichman, P Warde, T Gadalla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1990
Phase I/II trial of granisetron: a novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomitingM Addelman, C Erlichman, S Fine, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acidJ Steinberg, C Erlichman, T Gadalla, et al.
Pageof 10